Prophylactic treatment of preeclampsia;Prophylaxe der präeklampsie

Gynakologisch-geburtshilfliche Rundschau

Volumn 47, Issue 4, 2007, Pages 205-208

  Schauf, B ^a   Bohlmann, M K ^a   Wallwiener, D ^a   Abele, H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Aspirin; Heparin; Preeclampsia, prevention; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

ANAMNESIS; GENETIC DISORDER; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; PATHOPHYSIOLOGY; PREECLAMPSIA; PROPHYLAXIS; PROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; THROMBOPHILIA;

ANTICOAGULANTS; ASPIRIN; CLINICAL TRIALS; FEMALE; FIBRINOLYTIC AGENTS; GERMANY; HEPARIN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRE-ECLAMPSIA; PREGNANCY;

EID: 34948875847     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107260     Document Type: Review

References (11)

1. Bohlmann MK, Schauf B, Luedders DW, Wallwiener D, Strowitzki T, von Wolff M: Aktuelles zur rationellen Diagnostik und Therapie habitueller Frühaborte. Geburtsh Frauenheilkd 2007;67:217-227.
2. di Simone N, Caliandro D, Castellani R, Ferrazzani S, de Carolis S, Caruso A: Low-molecular weight heparin restores invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999;14:489-495.
3. Duley L, Henderson-Smart D, Knight M, King J: Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2004;1:CD004659.
4. Kramer M, Kakuma R: Energy and protein intake in pregnancy. Cochrane Database Syst Rev 2003;4:CD000032.
5. Meher S, Duley L: Exercise or other physical activity for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2006;2:CD005942.
6. Meher S, Duley L: Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev 2006;2:CD005939.
7. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
8. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA: The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) study - Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171-196.
9. Rumbold A, Crowther C, Haslam R, Dekker G, Robinson J: Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006;354:1796-1806.
10. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M, Dach-Liga Homocystein (German, Austrian and Swiss homocysteine society): Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003;41:1392-1403.
11. Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali M, Zavaleta N, Purwar M, Hofmeyr J, Nguyen T, Campodonico L, Landoulsi S, Carroli G, Lindheimer M: World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006;194:639-649.